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In Brief
Templeman, Luo, et al. provide evidence that insulin/IGF-1 signaling regulates reproductive and somatic aging through largely distinct mechanisms. Moreover, their transcriptomic approach indicates that cathepsin-B-like proteases negatively regulate oocyte quality with age, identifying a target to potentially slow age-related reproductive decline.
A decline in female reproduction is one of the earliest hallmarks of aging in many animals, including invertebrates and mammals [1] [2] [3] [4] . The insulin/insulin-like growth factor-1 signaling (IIS) pathway has a conserved role in regulating longevity [5] and also controls reproductive aging [2, 6] . Although IIS transcriptional targets that regulate somatic aging have been characterized [7, 8] , it was not known whether the same mechanisms influence reproductive aging. We previously showed that Caenorhabditis elegans daf-2 IIS receptor mutants extend reproductive span by maintaining oocyte quality with age [6] , but IIS targets in oocytes had not been identified. Here, we compared the transcriptomes of aged daf-2(À) and wild-type oocytes, and distinguished IIS targets in oocytes from soma-specific targets.
Remarkably, IIS appears to regulate reproductive and somatic aging through largely distinct mechanisms, although the binding motif for longevity factor PQM-1 [8] was also overrepresented in oocyte targets. Reduction of oocytespecific IIS targets decreased reproductive span extension and oocyte viability of daf-2(À) worms, and pqm-1 is required for daf-2(À)'s long reproductive span. Cathepsin-B-like gene expression and activity levels were reduced in aged daf-2(À) oocytes, and RNAi against cathepsin-B-like W07B8.4 improved oocyte quality maintenance and extended reproductive span. Importantly, adult-only pharmacological inhibition of cathepsin B proteases reduced age-dependent deterioration in oocyte quality, even when treatment was initiated in mid-reproduction. This suggests that it is possible to pharmacologically slow age-related reproductive decline through mid-life intervention. Oocyte-specific IIS target genes thereby revealed potential therapeutic targets for maintaining reproductive health with age.
RESULTS AND DISCUSSION

Identification of Oocyte-Specific IIS Transcriptional Targets
The insulin/insulin growth factor (IGF)-1-like signaling (IIS) pathway coordinates nutrient availability with energy homeostasis, in turn regulating lifespan and reproductive aging [2, 5, 6] . The extended longevity of C. elegans IIS receptor mutants (i.e., daf-2(À) worms) is dependent on transcriptional targets of the FoxO transcription factor DAF-16 [7, 8] , many of which are primarily expressed in the adult hypodermis and intestine [8] [9] [10] . However, developing oocytes are themselves transcriptionally active (before being silenced prior to fertilization), producing mRNAs for their own use and for embryonic development [11] , and IIS targets in oocytes had not been previously identified. Reproductive decline in both humans and C. elegans is largely due to deterioration of oocyte quality [6, 12] . Therefore, the identification of oocyte-specific IIS transcriptional targets may reveal mechanisms by which insulin/ IGF-1-like signaling slows reproductive aging and maintains oocyte quality with age.
Like daf-2(À) mutation, daf-2 RNAi doubles the mated reproductive span (i.e., period of adulthood with reproductive competence) of wild-type [6] and fem-1(hc17) (self-spermless) worms ( Figure 1A ). To identify IIS targets that regulate oocyte quality maintenance with age, we isolated unfertilized oocytes from control-and daf-2(RNAi)-treated fem-1(hc17) worms on day 8 of adulthood, when mated daf-2(À) worms still produce viable progeny but mated wild-type worms produce predominantly low-quality oocytes [6] . 126 genes were significantly upregulated, and 30 genes were significantly downregulated in aged daf-2(À) oocytes (false discovery rate [FDR] = 1%; Figures 1B and 1C; Data S1).
Many daf-2(RNAi) oocyte-upregulated genes have known functions related to the germline and/or reproduction. For instance, scl-19/dct-4, the gene with the highest significance analysis of microarrays (SAM) score, encodes an SCP-like extracellular protein that affects the formation of germline tumors [13] . DOD-6 (downstream of DAF-16) is predicted [14] to interact with IMA-3, an importin homolog essential for organizing the nuclear pore complex in the germline [15] . The metallothionein mtl-1 has a role in determining brood size [16] , and the triacylglycerol lipase lipl-4 regulates lifespan extension of germline-less worms by activating autophagy [17, 18] . These oocyte IIS targets are all Figure S1A ). This class included two small RNA pathway Argonaute proteins (alg-3 and -4) involved in male gametogenesis [19] and folt-1 (folate transporter 1, orthologous to human SLC19A folate transporters), which impacts germline formation and oogenesis [20] .
Many genes downregulated in daf-2(RNAi) oocytes encode proteins with functions in nutrient reservoir activity and lipid transport, as well as lysosomal and peptidase/proteolysis activity ( Figure S1C ). Vitellogenins (vit-2, vit-3, vit-4, vit-5 , and vit-6) encode major yolk components and are strong class II wholeworm IIS target genes (i.e., downregulated in daf-2(À) and upregulated in day 1 daf-16(À);daf-2(À) whole worms) [7] . Other canonical class II IIS targets downregulated in daf-2(RNAi) oocytes include dod-19 and the metallothionein mtl-2. 30% of the genes significantly downregulated in daf-2(RNAi) oocytes were not previously identified as IIS transcriptional targets [8] ( Figure S1A ). Four of the 30 downregulated genes are known or predicted cathepsin-B-like cysteine proteases (cpr-1, cpr-4, cpr-5, and W07B8.4), two of which (cpr-1 and W07B8.4) were not previously identified as IIS targets [8] .
Collectively, many genes that affect reproduction, germline formation and function, or oogenesis were regulated in the higher quality aged oocytes of daf-2 RNAi-treated worms, including oocyte-specific targets that were not previously known to be IIS regulated.
IIS Has Distinct Target Gene Sets in Oocytes versus Somatic Tissue
To determine the degree to which somatic IIS targets are similar to oocyte IIS targets, we compared the expression profiles of day 8 control-and daf-2(RNAi)-treated fem-1(hc17) whole worms (Figures S1D and S1E). We expected oocytelevel changes to account for some of the whole-worm differential expression (as whole worms contain oocytes); therefore, we compared whole-worm IIS target genes to isolated oocyte IIS targets. However, only 33 of the 465 genes that were upregulated ($7%) and 6 of the 459 genes that were downregulated ($1%) in daf-2(RNAi) whole worms were also significantly altered in isolated daf-2(RNAi) oocytes (Figures 1D and 1E ; Data S2); that is, more than 95% of the IIS targets detected in day 8 whole-worm assessments were soma specific ( Figures  S1D and S1E ). Pathways and functions associated with the oocyte-specific daf-2(RNAi)-regulated gene sets were largely distinct from those of the soma-specific sets (Figures S1B and S1C). The paucity of shared Gene Ontology (GO) terms suggests that daf-2(À)'s regulation of oocyte quality maintenance involves gene functions that are distinct from those that influence somatic aging.
IIS's regulation of reproductive and somatic aging can be dissociated both temporally and spatially. daf-2(RNAi) treatment after early adulthood does not alter reproductive span, whereas IIS actively regulates lifespan into adulthood [6, 21] . daf-2(À)-mediated reproductive span extension requires DAF-16 activity in the intestine and muscle, but not in neurons [6] , whereas lifespan extension of daf-2(À) worms requires DAF-16 in the intestine and hypodermis, but not in muscle [9, 22] . The somaspecific IIS target set is enriched for predicted hypodermal and/or intestinal genes [10] and depleted for neuronal and/or germline genes ( Figure S1F ), in agreement with previous work [8, 9] , suggesting that soma-specific IIS targets are more likely to impact somatic aging than reproductive aging. Figure S2D ) [7] . dod-6, a shared soma/oocyte IIS target gene, is required for both daf-2(e1370)'s longevity and extended reproductive span (p < 0.0001; Figures S2D and S2E). By contrast, life-long knockdown of soma-specific IIS targets gst-3 or sod-3, which are required for daf-2's longevity (Figure S2D ) [7] , but are not transcriptionally altered in daf-2(RNAi) oocytes, had no significant effect on daf-2(e1370)'s reproductive span ( Figure S2E ). IIS targets in the oocytes may therefore act cumulatively to impact reproductive aging.
Functional Analyses of IIS Oocyte Transcriptional Targets
Examining progeny viability further confirmed an effect of daf-2(RNAi) oocyte-upregulated targets on reproductive function. daf-2(À) worms normally produce healthy offspring past day 8 of adulthood [6] , but RNAi-mediated knockdown of F14F9.2, clec-60, or cyp-32A1 significantly inhibited hatching of embryos produced by daf-2(e1370) worms ( Figure 1F ). These results suggest that at least a subset of the highly upregulated daf-2(RNAi) oocyte genes contribute to IIS's regulation of oocyte quality maintenance with age. The DAE-Binding Factor PQM-1 Regulates Reproductive Aging Previously, we found that IIS target gene promoters are enriched for two motifs: TGTTTAC, the DAF-16-binding element (DBE), and CTTATCA, the DAF-16-associated element (DAE) [7] . DNA motif analysis of the 1 kb upstream of soma-specific and oocyte-specific IIS targets revealed that the DBE and DAE were overrepresented in promoter regions of the soma-specific, but not oocyte-specific, daf-2(RNAi)-upregulated genes (Figure S1G) . The DAE motif was overrepresented in the promoter regions of both the oocyte-specific and the soma-specific daf-2(RNAi) downregulated targets ( Figure S1H ), suggesting a regulatory role for this element in oocytes. The DAE motif is bound by the C2H2 Zn finger transcription factor PQM-1, a key component of daf-2 longevity [8] . We found that loss of pqm-1 also greatly reduced the reproductive span of daf-2 mutants (50%; p < 0.0001; Figure 1G ), indicating that PQM-1 plays a major role in determining IIS's effects on both somatic aging and reproductive aging.
Effects of Cathepsin-B-like Cysteine Proteases on Reproductive Aging
We were struck by the fact that four of the 30 IIS oocyte-specific downregulated genes (Figures 1C and 2A ; Data S1) encoded cathepsin-B-like proteases, and lysosomal and proteolysis/ peptidase activity were significantly enriched GO terms for oocyte-specific, but not somatic, daf-2(RNAi)-downregulated genes (Benjamini-Hochberg adjusted p values < 0.0016; Figure S1C). We noted that these genes also tended to be downregulated in day 8 high-quality transforming growth factor b (TGF-b) Sma/Mab(À) mutant oocytes and in young day 3 fem-1(hc17) oocytes compared to day 8 fem-1(hc17) oocytes ( Figure S3A) ; that is, cathepsin B proteases were downregulated in all high-quality oocyte conditions. Cathepsin B is a lysosomal cysteine protease involved in many mammalian physiological functions, including intra-and extracellular protein degradation and turnover, apoptosis, cleavage of extracellular matrix proteins, and key regulatory steps of cancer biology [23] . We found that whereas cathepsin B protease activity levels were low in the high-quality oocytes of young adult wild-type worms, by day 7 of adulthood, cathepsin B protease activity in the oocytes had more than tripled ( Figures 2B and S3B) . Importantly, day 7 daf-2(e1370) oocytes did not exhibit this age-dependent elevation in cathepsin B protease activity ( Figures 2B and S3B) , consistent with the lower expression of cathepsin-B-like genes in highquality aged daf-2(À) oocytes.
Deteriorating oocyte quality is a major cause of age-dependent reproductive decline [6, 12] . An increase in cathepsin B gene expression and protease activity with age could either be due to (1) a protective response to age-related damage or (2) the loss of suppression of a potentially deleterious activity. Directly reducing cathepsin B cysteine proteases should only improve oocyte quality with age in the latter case (i.e., if they are associated with a deleterious activity); loss of cathepsin B proteases in the former case should lead to increased oocyte damage. Therefore, we evaluated whether cathepsin B cysteine proteases affected oocyte quality with age by knocking down individual cathepsin-B-like genes in adult rrf-3(pk1426) (RNAisensitive) worms. Adult-only RNAi-mediated knockdown of the predicted cathepsin-B-like gene W07B8.4 increased reproductive span by $10% (p < 0.05; Figure S3D ). More strikingly, reduction of W07B8.4 significantly improved the morphology of aging oocytes, significantly reducing the frequency of irregularly shaped or abnormally small oocytes in day 5 mated rrf-3(pk1426) worms (Figures 2C and 2D) . These results suggested a deleterious role for at least one cathepsin-B-like gene in the regulation of reproductive aging, rather than an increase in cathepsin B protease activity due to an adaptive response to damage. Notably, any influences on reproductive aging appeared independent of somatic aging effects, as no change in lifespan was observed with adult-only knockdown of any of the individual cathepsin-B-like genes ( Figure S3F) .
We also explored whether pharmacological treatment of aging animals could improve the quality of aged oocytes. MDL-28170, a potent cell-permeable cathepsin B inhibitor utilized previously in C. elegans [24, 25] , broadly suppresses all cathepsin B proteases. Treatment of adult wild-type worms with MDL-28170 significantly slowed the decline of oocyte quality with age, as demonstrated by reduced incidences of cavities between oocytes, misshapen oocytes, and abnormally small oocytes in day 5 mated worms exposed to MDL-28170 after day 1 of adulthood, compared to DMSO-exposed controls ( Figures 3A  and 3B) .
Remarkably, initiating MDL-28170 treatment on day 3 of adulthood-an age at which oocyte quality and reproductive competence of wild-type worms has already begun to decline (e.g., Figure 1A )-still improved the quality of oocytes in aging worms ( Figures 3C and 3D ). This was particularly evident in the reduced incidence of severely small oocytes in day 7 mated worms treated with MDL-28170 from day 3 onward ( Figures  3C and 3D) .
MDL-28170 inhibits both cathepsin B and calpain cysteine proteases, although only the former were downregulated in high-quality daf-2(RNAi) oocytes (Figure 2A ). To distinguish between these classes of proteases, we also evaluated the effects of a calpain-specific inhibitor, PD-150606 [26] ; we found that this calpain inhibitor did not significantly affect oocyte morphology maintenance ( Figure 3E ), suggesting that cathepsin B inhibition is responsible for the improved oocyte quality we observed upon MDL-28170 treatment.
Together, our results show that inhibition of cathepsin B cysteine proteases significantly reduces age-dependent deterioration of oocyte quality. Moreover, significant improvements to oocyte quality were evident even when cathepsin B proteases were not inhibited until partway through the reproductive period, suggesting the potential for late-life interventions to slow reproductive aging.
Conclusions
In humans, the dramatic increase in rates of infertility, birth defects, and miscarriages occurs more than a decade before the exhaustion of oocyte supply (menopause), indicating that decreasing oocyte quality, rather than depletion, is the major contributing factor for reproductive aging [1, 12] . Reproductive decline in C. elegans is also caused by decreasing oocyte quality [2] [3] [4] 6] , and there appears to be a high degree of evolutionary conservation-spanning worms, mice, and humans-of molecular processes that regulate oocyte quality with age [2, 6, 27] . Here, we have uncovered a set of oocyte-specific IIS transcriptional targets that are largely distinct from soma-specific IIS targets, indicating that IIS regulates reproductive and somatic aging through distinct molecular mechanisms. We confirmed that a number of oocyte-specific IIS target genes regulate the maintenance of oocyte viability with age. Although the roles of IIS in reproductive and somatic maintenance are most likely coordinated, reproductive status decisions can be dissociated from lifespan regulation [28] , and a separate oocyte-specific IIS transcriptome could be one mechanism to fine-tune control of reproduction under stressful or nutrientpoor conditions. Distinct oocyte-and soma-specific IIS targets may also illustrate differences in regulating replicative versus non-replicative cells, as the only cells in adult C. elegans with the capacity for proliferation are germ cells. We identified a set of cysteine proteases whose inhibition during adulthood slows the decline of oocyte quality with age, indicating that cathepsin B proteases might affect the renewal and maintenance of oocyte competence with age. Intriguingly, the age-dependent increase in cathepsin B gene expression and protease activity is not likely to be in response to damage but rather a deleterious cause of oocyte aging, because cathepsin B inhibition preserves oocyte morphology with age. Suppressing a rise in cathepsin B protease activity in oocytes could be a mechanism by which aging daf-2(À) worms maintain oocyte quality. Interestingly, elevated cathepsin B mRNA and activity levels in cumulus cells are also associated with compromised developmental competence of bovine oocytes [29, 30] , suggesting that increased cathepsin B levels are an evolutionarily conserved process associated with decreased oocyte quality.
Our results demonstrate that it is possible to use a pharmacological agent to slow reproductive aging. Importantly, the success of cathepsin B inhibitor treatment of ''reproductively aged'' mothers suggests that this could be a viable approach for late-life interventions to slow age-related reproductive decline in mammals. Our study provides insights into fundamental mechanisms of oocyte quality control and suggests that a transcriptomic approach could uncover further mechanisms to extend reproductive span, facilitating the development of therapies to address the issue of maternal reproductive decline with age.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: fem-1;daf-2(RNAi) animals. RNA was extracted and purified using an RNeasy Mini Kit (QIAGEN, Germantown, MD, USA), cRNA was linearly amplified and Cy3/Cy5 labeled (Agilent, Santa Clara, CA, USA), and hybridized to Agilent 44k C. elegans microarrays, as previously performed [40] . In all cases, RNA used for hybridizing onto individual arrays was derived from biological replicates.
Microarray analyses
Data were filtered for quality (PUMAdb; http://puma.princeton.edu), and Cluster 3.0 was used for hierarchical clustering [33] . Oneclass SAM analyses (FDR = 1%) were performed in RStudio to identify day 8 daf-2(RNAi) oocyte targets and day 8 daf-2(RNAi) wholeworm targets [34] . Genes were submitted to DAVID 6.8 (https://david.ncifcrf.gov/) for Gene Ontology analysis [35] . Visualization of overlap between gene lists was generated using BioVenn (http://www.biovenn.nl/) [36] .
Tissue enrichment analyses Gene sets were submitted to http://worm-tissue.princeton.edu/ to determine tissue enrichment scores [10] .
Motif analyses 1 kb of 5 0 upstream sequences were retrieved and submitted to oligo-analysis using Regulatory Sequence Analysis Tools (RSAT) [37] to identify overrepresented sequences.
Reproductive span and lifespan assays As previously described [4] , self-fertilized or mated reproductive spans were performed by moving individually plated hermaphrodites to fresh plates daily until progeny production had ceased for two subsequent days; the last day of viable progeny production preceding two days without progeny was designated as the day of reproductive cessation (assessed by evaluating plates for progeny 1-2 days after the hermaphrodites had been moved off plates). Synchronized hermaphrodites were individually plated as L4 larvae for self-fertilized reproductive span assays, or mated to young (day 1) wild-type or fog-2(q71) males at a 1:3 ratio for 24 hr before being individually plated, with successful mating ascertained by evaluating the fraction of male progeny produced. Animals were censored on the day of matricide.
Lifespan assays were carried out in accordance with previously described protocols [4] . In brief, synchronized hermaphrodites ($10 per plate) were transferred away from progeny to fresh plates every 1-2 days, until the end of their reproductive period. Worms were designated as alive or dead based on their responsiveness to touch stimuli, with incidences of matricide, aberrant vulval structures, or lost/dehydrated worms leading to censoring on the day of the event. The first day of adulthood was defined as t = 0 for the standard Kaplan-Meier log-rank survival tests.
Progeny viability assay As previously described [6] , synchronized hermaphrodites were transferred to fresh plates every day, and each individual's daily production of embryos that failed to hatch or oocytes that were unfertilized (versus healthy, hatched embryos) was counted.
Magic Red cathepsin B activity assay
The Magic Red Cathepsin B Kit (Immunochemistry Technologies, Bloomington, MN, USA) was used, based on manufacturers' instructions and previous descriptions of use in C. elegans experiments [41] . In brief, Magic Red reagent dye dissolved in DMSO and further diluted with water was spread over 3 mL NGM plates previously seeded with OP50 E. coli, giving a final 1X concentration of the dye. Once the liquid had dried, hypochlorite-synchronized L4 larvae or mated day 6 adults (previously mated at a 1:2 ratio with fog-2(q71) males from the L4 stage to day 1 of adulthood) were placed on the plates and incubated at 20 C overnight in the dark, then cleared of residual dye by being placed on fresh plates seeded with OP50 E. coli for 35 min prior to imaging. The Magic Red reagent contains a target sequence peptide that is cleaved by cathepsin B to produce a red fluorescent product; red fluorescence intensity was measured using Nikon Elements Advanced Research software.
Oocyte morphology experiments For all oocyte morphology experiments, hypochlorite-synchronized hermaphrodites were placed on plates at a 1:2 ratio with fog-2(q71) males for at least 24 hr (from the L4 stage to day 1 of adulthood) for mating, and then maintained on plates without males or accumulating progeny from day 1 onward. For cathepsin B and/or calpain inhibition experiments, wild-type hermaphrodites were exposed to MDL-28170, PD-150606, or the DMSO control as either mated day 1 adults or, in the delayed treatment experiments, as mated day 3 adults. Individually plated mated hermaphrodites were exposed to a final concentration of 20 mM MDL-28170 (SigmaAldrich, St. Louis, MO, USA) [25] , 20 mM PD-150606 (Sigma-Aldrich) [26] , or Dimethylsulfoxide (DMSO; ATCC: The Global Bioresearch Center, Manassas, Virginia, USA) as the control. MDL-28170 and PD-150606 were both dissolved in DMSO to a concentration of 65.4 mM, and immediately before use, each stock mixture (or the same volume of DMSO alone) was diluted in water to 0.04 mM; 100 mL was spread over each 4 mL NGM plate, and plates were seeded with OP50 E. coli after the liquid had dried. Worms were transferred to these drug-treated plates within 24 hr, and were transferred to freshly treated plates every 24 or 48 hr until oocyte images were taken.
For scoring oocyte images, the image order was randomized and the scorer was blinded to the treatment represented in each image while assigning a score for each of the signs of deterioration according to the severity of the phenotype. Images were scored based on criteria described in [6] ; in brief, a score of either normal, mild, or severe was assigned for each category, based on the severity of the phenotype. With respect to the 'cavities' phenotype, normal indicated no cavities, mild indicated some loss of contact between oocytes, and severe indicated the presence of large splits between oocytes; with respect to the 'misshapen oocytes' category, normal indicated that all oocytes were similarly shaped (generally cuboidal), mild indicated some slight irregularities, and severe indicated one or more oocytes appearing damaged or very irregularly shaped; with respect to the 'small oocytes' category, normal indicated no small oocytes, mild indicated that the oocytes did not tend to fill the given space between the body wall and germline arm, and severe indicated incidences of very tiny oocytes; with respect to the 'oocytes in uterus' category, normal indicated no recognizable unfertilized oocytes in the uterus (only embryos), while mild indicated at least one recognizable unfertilized oocyte in the uterus, and severe indicated the presence of either multiple individual unfertilized oocytes or a clump of them in the uterus.
QUANTIFICATION AND STATISTICAL ANALYSIS
Lifespan and reproductive span assays were assessed using Kaplan-Meier log rank tests. The Friedman test (with Dunn's test for multiple comparisons) was used to compare the target gene RNAi-treated group versus the control RNAi-treated group with respect to the production of either unhatched embryos or unfertilized oocytes over time. To compare red fluorescence levels in oocytes for cathepsin B protease activity experiments, 2-way ANOVAs were used for evaluating effects of age (day 1 versus day 7) and genotype (wild-type versus daf-2(e1370)), with a significant interaction between factors (p < 0.0001) leading to the performance of Bonferroni post hoc comparisons to determine differences between individual groups. For oocyte quality experiments, chi square analyses were used to determine whether there were significant differences between populations for each category of scored oocyte phenotypes. Experiments were repeated on separate days with separate populations, to confirm that results were reproducible. Prism 7 software was used for all statistical analyses; software and further statistical details used for microarray analyses are described in the Method Details section of the STAR Methods. Additional statistical details of experiments, including sample size (with n representing the number of worms), can be found in the figure legends.
DATA AND SOFTWARE AVAILABILITY
Raw microarray dataset is publically available through PUMAdb (http://puma.princeton.edu).
